AKT1 and neoplasm: Immunoblotting with an anti-ErbB2 antibody demonstrated that the level of ErbB2 protein was dramatically increased in tumours of both origins compared with normal mammary tissue from the same mouse, from FVB mice or from myr-Akt1 transgenic mice (Figure 2a).